First Page | Meta Content | |
---|---|---|
Document Date: 2011-11-01 11:56:35Open Document File Size: 54,20 KBShare Result on FacebookCityLondon / /CompanyOgden / Medline / Chalmers I. Britain / /CountryNetherlands / United Kingdom / / /FacilityUniversity of Nijmegen / Royal College of Physicians / National Institute / /IndustryTermhealth services / health technology assessment programme / treatment of incurable disease / health technology assessment / /MedicalConditionJE / cancer / incurable disease / postmenopausal osteoporosis / leukaemia / cardiac arrhythmia / infection / sexually transmitted infection / /OrganizationGeneral Medical Council / Royal College of Physicians / University of Nijmegen / Consumers’ Association / Department of Health / NHS / Medical Research Council / National Institute for Clinical Excellence / /PersonWoods K. Filling / Andy Oxman / Richard Ashcroft / Angela Coulter / Kent Woods / Arch Intern / Jos Kleijnen / Trevor Sheldon / Wells G. Fluoride / Dave Sackett / Jan Vandenbroucke / Shah R. Doctors / John Williams / Connor S. Glaxo / Ann Oncol / Ray Tallis / Hazel Thornton / Alessandro Liberati / Paul Glasziou / James Lind Initiative / /Positioncoordinator / /SocialTag |